Mersana Therapeutics, Inc. - Common Stock (NQ:MRSN)

29.08 UNCHANGED

Last Price Updated: 4:00 PM EST, Jan 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Mersana Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

An Overview of Mersana Therapeutics's Earnings ↗

May 14, 2025

Via Benzinga

Top movers in Thursday's after hours session ↗

April 24, 2025

The regular session of the US market on Thursday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.

Via Chartmill

Earnings Scheduled For March 3, 2025 ↗

March 03, 2025

Via Benzinga

Earnings Scheduled For November 13, 2024 ↗

November 13, 2024

Via Benzinga

Earnings Preview For Mersana Therapeutics ↗

November 12, 2024

Via Benzinga

The Analyst Verdict: Mersana Therapeutics In The Eyes Of 5 Experts ↗

March 19, 2024

Via Benzinga

This Harrow Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday ↗

February 06, 2025

Via Benzinga

Why Is Cancer-Focused Mersana Therapeutics Stock Trading Lower On Friday? ↗

January 10, 2025

Mersana shares Phase 1 data on Emi-Le for TNBC and details FDA's Fast Track status for XMT-1660 in advanced HER2-low breast cancer.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

November 13, 2024

Via Benzinga

Why BloomZ Shares Are Trading Higher By Around 64%; Here Are 20 Stocks Moving Premarket ↗

October 10, 2024

Via Benzinga

Expert Outlook: Mersana Therapeutics Through The Eyes Of 5 Analysts ↗

February 29, 2024

Via Benzinga

A Preview Of Mersana Therapeutics's Earnings ↗

February 27, 2024

Via Benzinga

What To Know About Citigroup's Upgrade of Mersana Therapeutics ↗

December 04, 2023

Via Benzinga

A Preview Of Mersana Therapeutics's Earnings ↗

November 06, 2023

Via Benzinga

MRSN Stock Earnings: Mersana Therapeutics Misses EPS, Misses Revenue for Q2 2024 ↗

August 13, 2024

MRSN stock results show that Mersana Therapeutics missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.

Via InvestorPlace

MRSN Stock Earnings: Mersana Therapeutics Beats EPS, Beats Revenue for Q1 2024 ↗

May 09, 2024

MRSN stock results show that Mersana Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

Why Teledyne Technologies Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

April 24, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

March 15, 2024

Via Benzinga

Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

February 29, 2024

Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed fourth-quarter financial results.

Via Benzinga

Hormel Foods Reports Upbeat Earnings, Joins Pure Storage, Okta, Papa John's International And Other Big Stocks Moving Higher On Thursday ↗

February 29, 2024

U.S. stocks were higher, with the Nasdaq Composite gaining around 50 points on Thursday.

Via Benzinga

Topics Stocks

3 Biotech Stocks to Turn $10,000 Into $1 Million: January 2024 ↗

January 22, 2024

Biotech stocks are some of the most exciting opportunities on the market. Find the right ones with catalysts, and you could make a fortune.

Via InvestorPlace

Elli Lilly Joins Big Pharma’s Multi-Billion-Dollar Oncology Race

October 10, 2023

Large pharmaceutical companies are increasingly investing in cancer treatment stocks, driven by the promise of medical breakthroughs and financial rewards. Eli Lilly became the latest Big Pharma giant...

Via PressReach

Why KeyCorp Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

January 18, 2024

Shares of KeyCorp (NYSE: KEY) moved lower during Thursday’s session after the company reported fourth-quarter financial results. Revenues of $1.538 billion, down 19.0% Y/Y, slightly topped the...

Via Benzinga

How To Invest In The Healthcare Sector ↗

August 19, 2023

If things go wrong with some healthcare companies, investors often justify why they stay in the stock. And when things go right, they can go right in a hurry. Mersana Therapeutics is an example of how...

Via Talk Markets

Dow Dips Over 200 Points; McDonald's Tops Q2 Expectations ↗

July 27, 2023

U.S. stocks turned lower toward the end of trading on Thursday, with the Dow Jones falling more than 200 points . The Dow traded down 0.59% to 35,310.03 while the NASDAQ fell 0.44% to 14,064.61. The...

Via Benzinga

Why Avantor Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

July 28, 2023

Gainers Unique Fabricating, Inc. (NYSE: UFAB) shares jumped 113% to $0.4605 after gaining 12% on Thursday.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

July 27, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

July 27, 2023

During Thursday, 56 stocks hit new 52-week lows.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 28, 2023 ↗

July 28, 2023

Via Benzinga

Why Willis Towers Watson Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

July 27, 2023

Gainers Femasys Inc. (NASDAQ: FEMY) gained 54% to $0.55. Femasys reported a notice of allowance for new U.S. patent application covering use of FemBloc for female permanent birth control.

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.